Global Metabolism Drugs Market 2017 Global Metabolism Drugs Market 2017 | Page 5

9.8.3 Fuji yakuhin Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 LG Life Science
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Metabolism Drugs Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 LG Life Science Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Metsubishi Tanabe Pharma
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Metabolism Drugs Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Metsubishi Tanabe Pharma Metabolism Drugs Sales, Revenue, Price and Gross Margin
(2012-2017)
9.10.4 Main Business/Business Overview
10 Metabolism Drugs Maufacturing Cost Analysis
10.1 Metabolism Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Metabolism Drugs
10.3 Manufacturing Process Analysis of Metabolism Drugs
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Metabolism Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Metabolism Drugs Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat